About Philip Young
Philip Young is a director at Carlsmed.
Philip Young reports to the SEC as a director or major shareholder of 15 public companies, including Inspire Medical Systems (INSP), Intermolecular (IMI) and Box (BOX).
Philip Young first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Philip Young in the role, so the role may have started earlier or lasted longer.
II
Inspire Medical Systems, Inc.
10% owner
2018 · Public company (INSP)
II
Intermolecular Inc.
10% owner
2011 – 2018 · Public company (IMI)
BI
Box Inc.
10% owner
2015 – 2017 · Public company (BOX)
II
Intersect ENT, Inc.
10% owner
2014 – 2015 · Public company (XENT)
OI
OncoMed Pharmaceuticals Inc
10% owner
2013 – 2014 · Public company (OMED)
GI
Guidewire Software, Inc.
10% owner
2012 · Public company (GWRE)
MI
Maxlinear, Inc.
10% owner
2010 – 2012 · Public company (MXL)
AI
AtriCure, Inc.
10% owner
2006 – 2012 · Public company (ATRC)
MI
Meet Group, Inc.
10% owner
2011 · Public company (MEET)
II
Imperva Inc.
10% owner
2011 · Public company (IMPV)
OI
Occam Networks Inc.
10% owner
2006 – 2011 · Public company (OCNW)
ZC
Zoran Corp.
Director
2006 – 2010 · Public company (ZRAN)
AI
Altus Pharmaceuticals Inc.
10% owner
2006 – 2009 · Public company (ALTU)
ML
Mellanox Technologies, Ltd.
10% owner
2007 · Public company (MLNX)
Key Colleagues at Startups
The people Philip Young works with at each company, as listed on that company's latest Form D.
Carlsmed, Inc. · Form D/A, Feb 7, 2025
RM
Robert Mittendorff
Director
KB
Kevin O'Boyle
Director
LG
Leonard Greenstein
Executive officer
DS
Durall Scott
Executive officer
NC
Niall Casey
Executive officer and director
MC
Michael Cordonnier
Chief Executive Officer and director
KS
Kevin Sidow
Director
SS
Sharon Schulzki
Executive officer
SH
Shariq Hussain
Executive officer
JR
Jonathan Root
Director